Navigation Links
New Scan May Help Find Aggressive Prostate Tumors
Date:1/27/2010

Process is among several that use a variation of MRI technology

WEDNESDAY, Jan. 27 (HealthDay News) -- A new imaging technology promises to achieve the long-sought goal of singling out prostate cancers that are life-threatening and require the most aggressive treatment, researchers report.

Magnetic resonance spectroscopy, which provides information about the metabolic chemistry of suspected cancerous tissue, gave good results in a small trial in which its readings were compared with those of current measures of prostate cancer danger, according to a report published Jan. 27 in Science Translational Medicine.

"We see a good correlation with pathology defined by those methods," said Leo L. Cheng, an assistant professor of radiology and pathology at Harvard Medical School and a researcher at Massachusetts General Hospital.

Prostate cancers are common among older men, but most of them are so slow-growing that they pose no danger to life. Current diagnostic techniques, which include readings of blood levels of a protein, prostate-specific antigen, cannot pick out the dangerous tumors. Doctors can take a tissue sample by doing a biopsy, but they often miss the small but deadly portion of the cancer that is growing aggressively enough to be life-threatening.

In 2005, Cheng and his colleagues found that magnetic resonance spectroscopy could distinguish cancerous from normal prostate tissue by their metabolic profiles. That's because cancerous tissue produces different chemicals than normal tissue.

Their new study used magnetic resonance spectroscopy on five cancerous prostate glands removed from men with the diagnosis. The results of the scans were compared with those of the standard technique, which judges a cancer by the degree of disorder produced by the malignancy. Five of seven regions identified as cancerous by that method scored high on a magnetic resonance spectroscopy malignancy index. The other two regions were near the outer edges of the glands, where exposure to air made the magnetic resonance results less clear.

The same kind of analysis can be done without removing the prostate glands, so Cheng and his colleagues are moving toward a trial that would more resemble the work now done by doctors.

"We are doing a validation study," Cheng said. "Once these data are verified, we need to work with the electronics people to develop more sensitive probes. Once that part is overcome, everything can be applied."

The validation study will take "optimistically, one to three months," Cheng said. Getting data showing that the technology can be used in human patients "will take some time, a year or two," he said.

When and if it comes to human trials, "the most urgent issue is to guide biopsies," Cheng said. "By taking a chemical spectrum of tissue, we may be able to do better than pathology to tell how aggressive a tumor is."

The technology currently requires a magnetic field far more powerful than those in magnetic resonance imaging devices in current medical use, and so part of the program at Massachusetts General Hospital is an effort to make the method usable in less powerful devices, he said.

Cheng's program is one of a number of efforts aimed at applying magnetic resonance imaging to prostate cancer diagnosis. Another already is available commercially, marketed by iCAD Inc., a New Hampshire-based company.

The iCAD technology uses "dynamic contrast-enhanced" imaging, said Marc Filerman, vice president of global marketing for the company. Gadolinium, a contrast agent, is injected into the prostate gland "to produce images that better highlight where the potentially cancerous lesion might be," he said.

Gadolinium concentrates in regions where there are fast-growing blood vessels that the voracious expansion of cancerous tissue requires, he said. "Those blood vessels are leaky, and the resulting images enable us to quantify a potentially cancerous lesion, to see the effect of treatment," Filerman said.

Work to improve existing technologies is continuing, he said. "What we are trying to do in the magnetic resonance imaging community is to standardize on the best methodology for image acquisition and interpretation," Filerman explained.

More information

The U.S. National Cancer Institute has more on prostate cancer.



SOURCES: Leo L. Cheng, Ph.D., assistant professor, radiology and pathology, Harvard Medical School, and researcher, Massachusetts General Hospital, Boston; Marc Filerman, vice president, global marketing, iCAD Inc., Nashua, N.H.; Jan. 27, 2010, Science Translational Medicine, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Genetic Marker for Aggressive Prostate Cancer Found
2. More Aggressive Treatment for Weekend Stroke
3. Genetic variant associated with aggressive form of prostate cancer
4. Protein link may be key to new treatment for aggressive brain tumor
5. Aggressive Infection Control Program Protects Cancer Patients from Acquiring Clinic-Based H1N1 Influenza
6. AdCare Health Systems Completes Private Placement to Fund Aggressive Growth Initiatives
7. Pixantrone Produces 250% Relative Improvement in 1 Year Progression Free Survival for Patients With Relapsed/Refractory, Aggressive Non-Hodgkins Lymphoma Across All Measured Risk Factors - Updated Follow-Up Data
8. Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
9. MS is more aggressive in children but slower to cause disability than in adults
10. Elderly Treated Less Aggressively for Heart Attack
11. Nations hip fracture rate could drop 25 percent with aggressive osteoporosis prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... 25, 2016 , ... Consumer access to organic foods and grower access to ... of whole grain cereals and other plant-based foods, will introduce the first consumer product ... wheat processed by Hesco/Dakota Organic Products. , The transitional designation means the cereal was ...
(Date:5/25/2016)... ... 2016 , ... American Spine in Frederick, Maryland is pleased ... in the Montgomery County, Howard County and Washington, D.C. areas, renowned spine specialist, ... Spine every Monday. He will also perform surgeries in our Germantown surgical center ...
(Date:5/24/2016)... ... 24, 2016 , ... PhishLine, the best-in-class, enterprise level security ... Vice President of Sales. Cifolelli’s primary responsibilities include management of the company’s ... expanding field of organizational social engineering. , “We are delighted to have ...
(Date:5/24/2016)... ... May 24, 2016 , ... i2i, a national ... website at its “Transforming Outcomes” User Conference in Las Vegas on May 19-20, ... success to set the market standard for meaningful population health management. The ...
(Date:5/24/2016)... ... May 24, 2016 , ... Educational opportunities, and therefore life ... advantaged communities providing richer opportunities. Recognizing the key role of housing in this ... (b) school choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... 2016 Dutch surgeons have launched a ground-breaking ... world and treat patients on a global scale. Medical professionals from ... Asia and the US have already signed up ... networking in a totally secure environment. Education  ... working together with a surgeon at Harvard to treat a bomb ...
(Date:5/23/2016)... Mich. , May 23, 2016 Diplomat Pharmacy, ... third annual Fellowship and Internship programs. The hands-on learning ... The full-time, paid Fellowship and ... Flint, Michigan . Fellows and interns are provided ... Flint at the Riverfront Residence ...
Breaking Medicine Technology: